Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP504902.RARzKblkETebt0dctcasQqVW9gkerlxlj9vt-1SnJPKa0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP504902.RARzKblkETebt0dctcasQqVW9gkerlxlj9vt-1SnJPKa0130_assertion type Assertion NP504902.RARzKblkETebt0dctcasQqVW9gkerlxlj9vt-1SnJPKa0130_head.
- NP504902.RARzKblkETebt0dctcasQqVW9gkerlxlj9vt-1SnJPKa0130_assertion description "[Specifically, c-MYB (P </= 0.04) was significantly increased in ALL in the total fraction, whilst HOXA9 (P </= 0.19) and cystatin c (P </= 0.01) were increased in AML in the CD34(+) and CD34(-) fractions, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504902.RARzKblkETebt0dctcasQqVW9gkerlxlj9vt-1SnJPKa0130_provenance.
- NP504902.RARzKblkETebt0dctcasQqVW9gkerlxlj9vt-1SnJPKa0130_assertion evidence source_evidence_literature NP504902.RARzKblkETebt0dctcasQqVW9gkerlxlj9vt-1SnJPKa0130_provenance.
- NP504902.RARzKblkETebt0dctcasQqVW9gkerlxlj9vt-1SnJPKa0130_assertion SIO_000772 16029452 NP504902.RARzKblkETebt0dctcasQqVW9gkerlxlj9vt-1SnJPKa0130_provenance.
- NP504902.RARzKblkETebt0dctcasQqVW9gkerlxlj9vt-1SnJPKa0130_assertion wasDerivedFrom befree-2016 NP504902.RARzKblkETebt0dctcasQqVW9gkerlxlj9vt-1SnJPKa0130_provenance.
- NP504902.RARzKblkETebt0dctcasQqVW9gkerlxlj9vt-1SnJPKa0130_assertion wasGeneratedBy ECO_0000203 NP504902.RARzKblkETebt0dctcasQqVW9gkerlxlj9vt-1SnJPKa0130_provenance.